A treatment decision, not just a weight target
Medication-assisted weight management begins with an assessment of health history, weight-related conditions, previous care, and personal goals. A clinician may consider an approved weight-management product alongside nutrition and physical activity support. A brand used for diabetes should not automatically be assumed approved for weight management.
What follow-up should address
Follow-up needs to assess tolerability, nutritional intake, hydration, health measures, and changes in daily function. A lower appetite is not a reason to ignore inadequate food intake. Tell your clinician about persistent vomiting, severe abdominal pain, or trouble keeping fluids down. Seek prompt medical care for severe symptoms.
Set expectations you can evaluate
Ask how your clinician will decide whether treatment is helping and when the plan should be reconsidered. Weight can fluctuate, and trial averages do not predict an individual result. Discuss maintaining strength and longer-term support instead of judging success only by a short-term scale change.
Confirm the product and budget
Ask whether your proposed medication is FDA-approved or compounded and what risks apply. Compounded semaglutide is not FDA-approved. Review the initial and ongoing costs and what happens if coverage or affordability changes. Our Atlanta office can discuss an evaluation; a prescription is not guaranteed.